Table 3.

Progression-free and overall survival according to the use of beta-blockers.

Survival	Use of Beta-Blockers		p-Value
	No	Yes
Median PFS (95% CI)	8.30 months (7.80–9.57)	11.40 months (10.10–13.61)	0.006
3-month PFS (95% CI)	0.894 (0.863–0.925)	0.960 (0.926–0.995)
6-month PFS (95% CI)	0.665 (0.619–0.714)	0.766 (0.695–0.844)
12-month PFS (95% CI)	0.309 (0.264–0.361)	0.472 (0.392–0.571)
18-month PFS (95% CI)	0.136 (0.104–178)	0.185 (0.126–0.272)
Median OS (95% CI)	21.00 months (17.8–23.8)	26.8 months (22.20–32.20)	0.009
12-month OS (95% CI)	0.734 (0.689–0.781)	0.825 (0.760–0.896)
24-month OS (95% CI)	0.439 (0.388–0.497)	0.553 (0.465–0.656)
36-month OS (95% CI)	0.269 (0.223–0.326)	0.357 (0.271–0.471)